( MENAFN - PR Newswire) SAN DIEGO, May 28, 2024 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN ), a global leader in DNA sequencing and array-based technologies, today published its fifth annual Corporate Social Responsibility (CSR) Report. The report highlights the company's ongoing commitments and progress made in 2023 toward advancing human health by serving as a champion for patients, communities, employees, and the planet.
"At Illumina, we are guided by our mission to improve human health by unlocking the power of the genome," said Jacob Thaysen, CEO of Illumina. "Our customers, partners, and employees continue taking bold, meaningful steps to accelerate access to genomics, empower our communities, integrate environmental sustainability into our business strategy, nurture our people, and operate responsibly." Illumina's CSR program is rooted in four key focus areas, and the company's 2023 CSR Report demonstrates progress in each: The full report is available on Illumina's CSR website .
Forward-Looking Statements This communication contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding mandates, the future, business plans and other statements that are not historical in nature. These statements are made on the basis of Illumina's views and assumptions regarding future events and business performance and plans as of the time the statements are made. These forward-looking statements may be.
